Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- REGULATORY NEWS IN BRIEF
July 5, 2004
- DIAGNOSTICS NEWS IN BRIEF
July 5, 2004
- Pension Reform Bill Was the Main Achievement: Dr Sakaguchi
July 5, 2004
- MEDICAL DEVICE NEWS IN BRIEF
July 5, 2004
- Korosho to Draft GL for Life-sustaining Treatment in Terminal Care
July 5, 2004
- NEW PRODUCTS
July 5, 2004
- Sedative GL to Be Published in 2004: JSPM
July 5, 2004
- Meet the Leaders (34)
July 5, 2004
- NHO's Clinical Trial Network to Begin Large-scale Trials in 2004
July 5, 2004
- Average Monthly Wage Increases \5,921 at 21 Major Drug Makers
July 5, 2004
- Healthcare Reform Discussions Should Seek Balance Between Cost, Quality: Dr Aoki of JPMA
July 5, 2004
- BUSINESS NEWS IN BRIEF
July 5, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 5, 2004
- WEBSITE NEWS
July 5, 2004
- Need for New Drug Pricing System Stressed: Korosho Conference
June 28, 2004
- ICH Topics Q8, Q9 Should Reach Step 2 in November
June 28, 2004
- REGULATORY NEWS IN BRIEF
June 28, 2004
- 40,000 May Have Died Due to Medical Malpractice in 2003: Symposium
June 28, 2004
- Nearly 80% of Public Hospitals Posted Deficits in FY2002
June 28, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 28, 2004
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…